ORBIMED CAPITAL GP II LLC's Net Worth
$32.3 Million
Who is ORBIMED CAPITAL GP II LLC?
ORBIMED CAPITAL GP II LLC has an estimated net worth of $32.3 Million. This is based on reported shares across multiple companies, which include INSULET CORP, Volcano Corp, SUPERNUS PHARMACEUTICALS INC, AVANIR PHARMACEUTICALS, ACCELERON PHARMA INC, CRYOCOR INC, and GIVEN IMAGING LTD.
SEC CIK
ORBIMED CAPITAL GP II LLC's CIK is 0001281668
Past Insider Trading and Trends
2013 was ORBIMED CAPITAL GP II LLC's most active year for acquiring shares with 12 total transactions. ORBIMED CAPITAL GP II LLC's most active month to acquire stocks was the month of August. 2013 was ORBIMED CAPITAL GP II LLC's most active year for disposing of shares, totalling 16 transactions. ORBIMED CAPITAL GP II LLC's most active month to dispose stocks was the month of August. 2012 saw ORBIMED CAPITAL GP II LLC paying a total of $5,500,000.00 for 3,599,998 shares, this is the most they've acquired in one year. In 2006 ORBIMED CAPITAL GP II LLC cashed out on 3,880,396 shares for a total of $12,726,339.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INSULET CORP (PODD) Snapshot price: $199.08
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Volcano Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.37M |
—
|
—
| 2.37M |
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SUPERNUS PHARMACEUTICALS INC (SUPN) Snapshot price: $27.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.68% | -302.18K |
$7.55 | -$2,281,045.09 | 6.15M |
Feb 12 - Feb 13
| |||
Form 4
| -100.00% | -297.81K |
$6.92 | -$2,062,287.34 |
0
|
Dec 17 - Dec 18
| |||
Form 4
| +144.00% | 3.6M |
$5.00 | $5,500,000.00 | 6.1M |
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AVANIR PHARMACEUTICALS No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -26.94% | -629.12K |
$9.79 | -$6,159,094.59 | 1.71M |
May 31
| |||
Form 4
| -26.94% | -629.12K |
$9.79 | -$6,159,094.59 | 1.71M |
May 31
| |||
Form 4
|
∞
| 2.34M |
—
|
—
| 2.34M |
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACCELERON PHARMA INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.75% | 2.11M |
—
|
—
| 11.38M |
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |